5 results on '"Kantardjiev T"'
Search Results
2. Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017
- Author
-
Lepuschitz, S., Ruppitsch, W., Pekard-Amenitsch, S., Forsythe, S.J., Cormican, M., Mach, R.L., Pierard, D., Allerberger, F., Andrasevic, A.T., Balode, A., Barbut, F., Codita, I., Connican, M., Ferguson, C., Heczko, P., Holy, O., Kantardjiev, T., Kuijper, E.J., Leegaard, T.M., Peixe, L.M.V., Rautelin, H., Rupnik, M., Schonning, K., Stephan, R., Toniolo, A., Tosic, T., Valdezate, S., Muller, L. von, Zerva, L., Zinieri-Panayide, B., EUCRONI Study Grp, Supporting clinical sciences, Microbiology and Infection Control, Clinical Biology, University of Zurich, and Lepuschitz, Sarah
- Subjects
0301 basic medicine ,Male ,Epidemiology ,Cronobacter sakazakii/classification ,lcsh:Medicine ,phylogeny ,2726 Microbiology (medical) ,0302 clinical medicine ,Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017 ,Cronobacter ,bacteria ,Enterobacteriaceae Infections ,Genomics ,Subtyping ,Anti-Bacterial Agents ,Europe ,genome sequencing ,food safety ,Infectious Diseases ,whole-genome sequencing ,Microbiology (medical) ,030106 microbiology ,030231 tropical medicine ,610 Medicine & health ,Microbial Sensitivity Tests ,Biology ,History, 21st Century ,Microbiology ,lcsh:Infectious and parasitic diseases ,Anti-Bacterial Agents/pharmacology ,Enterobacteriaceae Infections/epidemiology ,Europe/epidemiology ,03 medical and health sciences ,Antibiotic resistance ,Cronobacter sakazakii ,Drug Resistance, Bacterial ,Humans ,lcsh:RC109-216 ,Typing ,10082 Institute of Food Safety and Hygiene ,whole ,Research ,lcsh:R ,Infant, Newborn ,Outbreak ,2725 Infectious Diseases ,biology.organism_classification ,bacterial typing ,public health surveillance ,outbreak investigation ,Genomics/methods ,Molecular Typing ,Multicenter study ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,Whole genome sequencing ,foodborne diseases ,Multilocus sequence typing ,570 Life sciences ,biology ,Genome, Bacterial ,2713 Epidemiology ,Multilocus Sequence Typing - Abstract
Cronobacter sakazakii has been documented as a cause of life-threating infections, predominantly in neonates. We conducted a multicenter study to assess the occurrence of C. sakazakii across Europe and the extent of clonality for outbreak detection. National coordinators representing 24 countries in Europe were requested to submit all human C. sakazakii isolates collected during 2017 to a study center in Austria. Testing at the center included species identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, subtyping by whole-genome sequencing (WGS), and determination of antimicrobial resistance. Eleven countries sent 77 isolates, including 36 isolates from 2017 and 41 historical isolates. Fifty-nine isolates were confirmed as C. sakazakii by WGS, highlighting the challenge of correctly identifying Cronobacter spp. WGS-based typing revealed high strain diversity, indicating absence of multi-national outbreaks in 2017, but identified 4 previously unpublished historical outbreaks. WGS is the recommended method for accurate identification, typing, and detection of this pathogen.
- Published
- 2019
3. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe
- Author
-
Struelens, M. J., Monnet, D. L., Magiorakos, A. P., Santos O'Connor, F., Giesecke, J., Grisold, A., Zarfel, G., Jans, B., Velinov, T., Kantardjiev, T., Alexandrou, M., Zemlickova, H., Hrabak, J., Frimodt Møller, N., Hammerum, A. M., Maimets, M., Ivanova, M., Jalava, J., Rummukainen, M., Eckmanns, T., Kaase, M., Dedoukou, X., Vatopoulos, A., Böröcz, K., Kristinsson, K. G., Gudlaugsson, O., Cunney, R., Rossolini, GIAN MARIA, Pantosti, A., Dumpis, U., Balode, A., Valinteliene, R., Weicherding, P., Leverstein van Hall, M. A., Huijsdens, X., Samuelsen, Ø., Simonsen, G. S., Hryniewicz, W., Gniadkowski, M., Costa, A. C., Caniça, M., Codita, I., Serban, R., Siegfried, L., Stefkovicova, M., Kolman, J., Pirš, M., Oteo, J., Campos, J., Tegmark Wisell, K., Edquist, P., Livermore, D., and Woodford, N.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Adolescent ,Epidemiology ,Prevalence ,Guidelines as Topic ,Microbial Sensitivity Tests ,Polymerase Chain Reaction ,Risk Assessment ,beta-Lactamases ,Young Adult ,Antibiotic resistance ,Enterobacteriaceae ,Virology ,Environmental health ,Surveys and Questionnaires ,Health care ,medicine ,media_common.cataloged_instance ,Humans ,Beta-lactamase ,European union ,Child ,Disease Notification ,media_common ,Aged ,Aged, 80 and over ,biology ,business.industry ,Resistência aos Antimicrobianos ,Public health ,Incidence ,Public Health, Environmental and Occupational Health ,Enterobacteriaceae Infections ,Middle Aged ,New Delhi metallo-beta-lactamase 1 ,Europe ,Phenotype ,Carbapenems ,Child, Preschool ,Population Surveillance ,biology.protein ,business - Abstract
The European NDM-1 Survey Participants: Manuela Caniça (Departamento de Doenças Infecciosas do INSA) Acquired carbapenemases confer extensive antibiotic resistance to Enterobacteriaceae and represent a public health threat. A novel acquired carbapenemase, New Delhi metallo-beta-lactamase 1 (NDM-1), has recently been described in the United Kingdom and Sweden, mostly in patients who had received care on the Indian subcontinent. We conducted a survey among 29 European countries (the European Union Member States, Iceland and Norway) to gather information on the spread of NDM-1-producing Enterobacteriaceae in Europe, on public health responses and on available national guidance on detection, surveillance and control. A total of 77 cases were reported from 13 countries from 2008 to 2010. Klebsiella pneumoniae was the most frequently reported species with 54%. Among 55 cases with recorded travel history, 31 had previously travelled or been admitted to a hospital in India or Pakistan and five had been hospitalised in the Balkan region. Possible nosocomial acquisition accounted for 13 of 77 cases. National guidance on NDM-1 detection was available in 14 countries and on NDM-1 control in 11 countries. In conclusion, NDM-1 is spreading across Europe, where it is frequently linked to a history of healthcare abroad, but also to emerging nosocomial transmission. National guidance in response to the threat of carbapenemase-producing Enterobacteriaceae is available in approximately half of the surveyed European countries. Surveillance of carbapenemase- producing Enterobacteriaceae must be enhanced in Europe and effective control measures identified and implemented.
- Published
- 2010
4. An overviev of the epidemiology and epizootiology of brucellosis in selected countries of Central and Southeast Europe
- Author
-
Taleski, V., Zerva, L., Kantardjiev, T., Cvetnić, Željko, Ersić-Biljić, M., Nikolovski, B., Bosnjakovski, J., Katalinić-Janković, V., Panteliadou, A., Stojkoski, S., and Kiradziski, T.
- Subjects
Brucellosis ,epidemiology ,epizootiology ,Macedonia ,Greece ,Bulgaria ,Croatia ,Yugoslavia - Abstract
The objective of this paper is to give an overview of the epidemiologic and epizootic status of brucellosis in selected countries of Central and Southeast Europe(Balkan region). Based ondimension of the disease problem, there is a need to establish collaboration in the eradication and prevention of brucellosis between all countries in the region. Althought there were no readily accessible data concerning epidemiology and epizootiology of brucellosis in these contries, the limited official and published data were analyzed. The incidence of brucellosis caused by Brucella melitensis in sheep, goats and human is very significant problem in Macedonia and Greece. in Greece, cattle are also affected either by B. melitensis or B. abortus. the disease is an endemic problem in some regions of Yugoslavia and includes B. suis biovar 2 in pig and in Croatia. B. melitensis in sheep, goats and human is found occasionally. No problem appears to exist with brucellosis in Bulgaria. Financial well-supported brucellosis control programs of the European Union that will include all countries, regardless of the magnitude of brucellosis incidence, are needed for eradication and control of brucellosis.
- Published
- 2002
5. Occurrence and characterization of Salmonella enterica subspecies enterica serovar 9,12:l,v:- strains from Bulgaria, Denmark, and the United States.
- Author
-
Petrov, P., Hendriksen, R. S., Kantardjiev, T., Asseva, G., Sørensen, G., Fields, P., Mikoleit, M., Whichard, J., McQuiston, J. R., Torpdahl, M., Aarestrup, F. M., and Angulo, F. J.
- Subjects
SALMONELLA ,PULSED-field gel electrophoresis ,MICROBIAL sensitivity tests ,EPITOPES ,FOOD pathogens ,PATHOLOGICAL laboratories ,EPIDEMIOLOGY ,INFECTIOUS disease transmission - Abstract
In 2006, Salmonella enterica serovar I 9,12:l,v:- emerged in Bulgaria. The aim of this study was to characterize Salmonella serovar I 9,12:l,v:- isolates from Bulgaria, Denmark, and the United States. We compared isolates of Salmonella I 9,12:l,v:- and diphasic serovars with similar antigenic formulas by pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility. The phase 2 flagellin gene ( fljB) was also sequenced for selected isolates. By PFGE, the Salmonella I 9,12:l,v:- isolates from Bulgaria were indistinguishable from the isolate from the United States and distinct from isolates from Denmark; furthermore, several Salmonella I 9,12:l,v:- were indistinguishable from an isolate of Salmonella serovar Goettingen. Sequence analysis showed 100% sequence identity with known H:e,n,z15 sequences of Salmonella Goettingen, which has the antigenic formula I 9,12:l,v:e,n,z15. The study indicated that Salmonella I 9,12:l,v:- is a monophasic variant of Salmonella Goettingen and is present in different countries and on different continents. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.